Skip to Main Content
Try STAT+ TODAY
Trending:
Health
The Obesity Revolution
Biotech
STAT+

2020 STAT Summit Breakout Sessions

You’ll be joining us at the 2020 STAT Summit on the Attendee Pass. This pass gives you unlimited access to all programming, including exclusive breakout sessions featuring our keynote speakers.

We will be hosting a block of simultaneous breakout sessions Nov. 16 – 18. You’ll be invited to attend one of them each day.

Please take a few minutes to tell us your preferences for each day’s sessions. We’ll do our best to accommodate your choices.

To rank your sessions, drag and drop each option to move them in the order you would like.

Questions? Email us at [email protected].

*Required

Please provide the following information for the person registered for an Attendee Pass so we can match the session preferences to the contact.
Name*
Breakout sessions, Day 1: November 16
Below are the five sessions we'll be hosting on the first day of the Summit. You will be assigned to one of them.

  • Merck’s new research
    — Dean Li, M.D., Ph.D., senior vice president, Discovery Sciences and Translational Medicine, Merck Research Laboratories
  • Hitting heart attacks, genetically
    — Sekar Kathiresan, M.D., co-founder and chief executive officer, Verve Therapeutics
  • Covid-19: What’s ahead
    — Caitlin M. Rivers, Ph.D., assistant professor, John Hopkins Bloomberg School of Public Health;
    Dara Kass, M.D., FACEP, emergency medicine physician, Founder of FemInEM
  • Tracking cancer with a blood test
    — Priti Hegde, Ph.D., chief scientific officer, Foundation Medicine
  • Thinking like a top investor
    — Behzad Aghazadeh, Ph.D, managing partner & portfolio manager, Avoro Capital Advisors
Breakout sessions, Day 2: November 17
Below are the five sessions we'll be hosting on the second day of the Summit. You will be assigned to one of them.

  • Navigating rapid innovation in health care — David Cordani, president and CEO, Cigna Corporation
  • Genetics and the brain — Tshaka Cunningham, Ph.D., co-founder and chief scientific officer, TruGenomix Inc.
  • CRISPR diagnostics — Janice Chen, Ph.D., co-founder & CTO, Mammoth Biosciences
  • Using CRISPR in therapeutics — Benjamin L. Oakes, Ph.D., co-founder, president and CEO, Scribe Therapeutics
  • Inside Bristol’s pipeline — Samit Hirawa, chief medical officer, Bristol-Myers Squibb
Breakout sessions, Day 3: November 18
Below are the five sessions we'll be hosting on the third day of the Summit. You will be assigned to one of them.

  • Launching a drug in a pandemic
    — Ted W. Love, M.D., president and chief executive officer, Global Blood Therapeutics
  • Prescription 2021
    — Speaker TBD
  • Antibody quest
    — George D. Yancopoulos, M.D., Ph.D., co-founder, president, and chief scientific officer, Regeneron
  • A VC’s view
    — Pearl Huang, Ph.D., president & CEO, Cygnal Therapeutics
  • A drug hunter looks at the pandemic
    — George Scangos, Ph.D., chief executive officer and director, Vir Biotechnology
Privacy Policy